Does BELATACEPT Cause Diffuse large b-cell lymphoma? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Diffuse large b-cell lymphoma have been filed in association with BELATACEPT (NULOJIX). This represents 0.9% of all adverse event reports for BELATACEPT.
29
Reports of Diffuse large b-cell lymphoma with BELATACEPT
0.9%
of all BELATACEPT reports
20
Deaths
28
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From BELATACEPT?
Of the 29 reports, 20 (69.0%) resulted in death, 28 (96.6%) required hospitalization, and 23 (79.3%) were considered life-threatening.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELATACEPT. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does BELATACEPT Cause?
Off label use (304)
Death (206)
Transplant rejection (178)
Cytomegalovirus infection (142)
Drug ineffective (142)
Product storage error (142)
Acute kidney injury (137)
Covid-19 (129)
Hospitalisation (123)
Kidney transplant rejection (97)
What Other Drugs Cause Diffuse large b-cell lymphoma?
RITUXIMAB (1,571)
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
Which BELATACEPT Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
BELATACEPT vs BELIMUMAB
BELATACEPT vs BELINOSTAT
BELATACEPT vs BELUMOSUDIL
BELATACEPT vs BELVIQ
BELATACEPT vs BELZUTIFAN